These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 34248627
21. Oxidized low-density lipoprotein inhibits THP-1-derived macrophage autophagy via TET2 down-regulation. Li G, Peng J, Liu Y, Li X, Yang Q, Li Y, Tang Z, Wang Z, Jiang Z, Wei D. Lipids; 2015 Feb; 50(2):177-83. PubMed ID: 25503193 [Abstract] [Full Text] [Related]
22. Tongxinluo Attenuates Myocardiac Fibrosis after Acute Myocardial Infarction in Rats via Inhibition of Endothelial-to-Mesenchymal Transition. Yin Y, Zhang Q, Zhao Q, Ding G, Wei C, Chang L, Li H, Bei H, Wang H, Liang J, Jia Z. Biomed Res Int; 2019 Feb; 2019():6595437. PubMed ID: 31317035 [Abstract] [Full Text] [Related]
23. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice. Ma L, Ni M, Hao P, Lu H, Yang X, Xu X, Zhang C, Huang S, Zhao Y, Liu X, Zhang Y. Oncotarget; 2016 Mar 29; 7(13):16194-204. PubMed ID: 26908443 [Abstract] [Full Text] [Related]
24. Fibroblast growth factor 21 regulates foam cells formation and inflammatory response in Ox-LDL-induced THP-1 macrophages. Wang N, Li JY, Li S, Guo XC, Wu T, Wang WF, Li DS. Biomed Pharmacother; 2018 Dec 29; 108():1825-1834. PubMed ID: 30372888 [Abstract] [Full Text] [Related]
25. Chinese medicine Tongxinluo reduces atherosclerotic lesion by attenuating oxidative stress and inflammation in microvascular endothelial cells. Wu XL, Zheng B, Jin LS, Zhang RN, He M, Yang Z, Wen JK. Int J Clin Exp Pathol; 2015 Dec 29; 8(6):6323-33. PubMed ID: 26261508 [Abstract] [Full Text] [Related]
26. SIRT1 inhibition promotes atherosclerosis through impaired autophagy. Yang X, Wei J, He Y, Jing T, Li Y, Xiao Y, Wang B, Wang W, Zhang J, Lin R. Oncotarget; 2017 Aug 01; 8(31):51447-51461. PubMed ID: 28881659 [Abstract] [Full Text] [Related]
27. A novel antioxidant Mito-Tempol inhibits ox-LDL-induced foam cell formation through restoration of autophagy flux. Ma Y, Huang Z, Zhou Z, He X, Wang Y, Meng C, Huang G, Fang N. Free Radic Biol Med; 2018 Dec 01; 129():463-472. PubMed ID: 30321700 [Abstract] [Full Text] [Related]
28. Combination of Hydroxyl Acetylated Curcumin and Ultrasound Induces Macrophage Autophagy with Anti-Apoptotic and Anti-Lipid Aggregation Effects. Zheng L, Li Y, Li X, Kou J, Zhong Z, Jiang Y, Liu Z, Tian Y, Yang L. Cell Physiol Biochem; 2016 Dec 01; 39(5):1746-1760. PubMed ID: 27744450 [Abstract] [Full Text] [Related]
29. Cyclophilin A mediates the ox-LDL-induced activation and apoptosis of macrophages via autophagy. Xue Z, Yuan W, Li J, Zhou H, Xu L, Weng J, Li X, Zhang X, Wang Z, Yan J. Int J Cardiol; 2017 Mar 01; 230():142-148. PubMed ID: 28038796 [Abstract] [Full Text] [Related]
30. PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats. Yu ZH, Cai M, Xiang J, Zhang ZN, Zhang JS, Song XL, Zhang W, Bao J, Li WW, Cai DF. J Ethnopharmacol; 2016 Apr 02; 181():8-19. PubMed ID: 26805466 [Abstract] [Full Text] [Related]
31. Danhong Injection Attenuates High-Fat-Induced Atherosclerosis and Macrophage Lipid Accumulation by Regulating the PI3K/AKT Insulin Pathway. Zhou M, Ren P, Li S, Kang Q, Zhang Y, Liu W, Shang J, Gong Y, Liu H. J Cardiovasc Pharmacol; 2019 Aug 02; 74(2):152-161. PubMed ID: 31306371 [Abstract] [Full Text] [Related]
32. Macrophage iron retention aggravates atherosclerosis: Evidence for the role of autocrine formation of hepcidin in plaque macrophages. Xiao L, Luo G, Guo X, Jiang C, Zeng H, Zhou F, Li Y, Yu J, Yao P. Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb 02; 1865(2):158531. PubMed ID: 31666189 [Abstract] [Full Text] [Related]
33. Propofol Ameliorates ox-LDL-Induced Endothelial Damage Through Enhancing Autophagy via PI3K/Akt/m-TOR Pathway: A Novel Therapeutic Strategy in Atherosclerosis. Zhou H, Jiang F, Leng Y. Front Mol Biosci; 2021 Feb 02; 8():695336. PubMed ID: 34250023 [Abstract] [Full Text] [Related]
34. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis. Gong M, Zhuo X, Ma A. Med Sci Monit Basic Res; 2017 Jun 15; 23():240-249. PubMed ID: 28615615 [Abstract] [Full Text] [Related]
35. [Inhibitory effect and acting mechanism of Tongxinluo on IL-1beta-mediated coronary intimal hyperplasia and 5-hydroxytryptamine-induced coronary vasospasm in small swine]. Guan QG, Zeng DY, Sun XZ. Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jul 15; 28(7):627-31. PubMed ID: 18822914 [Abstract] [Full Text] [Related]
36. Silencing Protease-Activated Receptor-2 alleviates ox-LDL-induced lipid accumulation, inflammation and apoptosis via activation of Wnt/β-catenin signaling. Liu Y, Wei M, Liu G, Song C, Yang M, Cao Z, Zheng M. Gen Physiol Biophys; 2020 Sep 15; 39(5):437-448. PubMed ID: 33084597 [Abstract] [Full Text] [Related]
37. Tongxinluo enhances the effect of atorvastatin on the treatment of atherosclerosis with chronic obstructive pulmonary disease by maintaining the pulmonary microvascular barrier. Kuang X, Wang Y, Liu S, Chang L, Yin Y, Li Z, Liu Y, Li W, Hou Y, Wang H, Liang J, Jia Z. Food Sci Nutr; 2023 Jan 15; 11(1):390-407. PubMed ID: 36655081 [Abstract] [Full Text] [Related]
38. Celosins inhibit atherosclerosis in ApoE-/- mice and promote autophagy flow. Tang Y, Wu H, Shao B, Wang Y, Liu C, Guo M. J Ethnopharmacol; 2018 Apr 06; 215():74-82. PubMed ID: 29292046 [Abstract] [Full Text] [Related]
39. Intervention of Tongxinluo capsule against vascular lesion of atherosclerosis and its effect on lectin-like oxidized low density lipoprotein receptor-1 expression in rabbits. Yu YH, Xu XQ, Wang Y, Sun SZ, Chen Y. Chin J Integr Med; 2006 Mar 06; 12(1):32-6. PubMed ID: 16571281 [Abstract] [Full Text] [Related]
40. Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1. Chen GH, Xu CS, Zhang J, Li Q, Cui HH, Li XD, Chang LP, Tang RJ, Xu JY, Tian XQ, Huang PS, Xu J, Jin C, Yang YJ. Front Pharmacol; 2017 Mar 06; 8():775. PubMed ID: 29163161 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]